United States· US:87026-202_46064e69-cc1a-8cee-e063-6394a90a8d32
SODIUM SULFACETAMIDE, SULFUR
A medicinal product containing sulfacetamide sodium; sulfur, registered in United States by Aspen Medical LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SULFACETAMIDE SODIUM; SULFUR
- Manufacturer
- Aspen Medical LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc118702620206170 g in 1 BOTTLE (87026-202-06)
- ndc118702620212340 g in 1 BOTTLE (87026-202-12)
- ndc1187026-202-06
- ndc1187026-202-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d91d9698-252f-4179-8559-cddde1f1e91a GET /v1/drugs/d91d9698-252f-4179-8559-cddde1f1e91a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "100; 50",
"substance": "SULFACETAMIDE SODIUM; SULFUR",
"productndc": "87026-202",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "mg/g; mg/g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about sulfacetamide sodium; sulfur.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.